Related Experiment Videos
Computerized scoring of histopathology for predicting coronary vasculopathy, validated by intravascular ultrasound
Mohamad H Yamani1, E Murat Tuzcu, Randall C Starling
1Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Kaufman Center for Heart Failure, Ohio 44195, USA. yamanim@ccf.org
Insights
A new biopsy score effectively predicts coronary vasculopathy after heart transplant. This tool aids in identifying high-risk patients for better outcomes in cardiac transplant recipients.
Area of Science:
- Cardiology
- Transplantation immunology
- Pathology
Background:
- Allograft coronary vasculopathy involves complex immunologic and non-immunologic factors.
- Histopathology of cardiac allografts is crucial for understanding post-transplant complications.
Purpose of the Study:
- To develop and validate a computerized histopathology-based biopsy scoring method.
- To predict the development and progression of coronary vasculopathy in heart transplant recipients.
Main Methods:
- Serial intravascular ultrasound and endomyocardial biopsies were analyzed in 140 heart transplant recipients.
- A mathematical model computed a biopsy score (RY) based on histopathology duration and severity.
- Coronary vasculopathy was assessed by changes in coronary maximal intimal thickness (CMIT).
Main Results:
- A significant correlation was found between biopsy score (RY) and coronary vasculopathy progression (r = 0.54, p = 0.001).
- An RY value ≥560 predicted coronary vasculopathy development with 86% sensitivity and 80% accuracy.
- High-risk scores (RY ≥560) correlated with increased CMIT progression and worse 7-year event-free survival.
Conclusions:
- The developed biopsy score is an effective tool for predicting coronary vasculopathy development.
- This scoring method aids in predicting patient outcomes following cardiac transplantation.
Background:
Allograft coronary vasculopathy results from a complex interplay between immunologic and non-immunologic factors. We devised a computerized biopsy scoring method based on histopathology to predict the development of coronary vasculopathy.
Methods:
One hundred forty heart transplant recipients underwent serial intravascular ultrasound analysis at baseline (within 1 month) and at 1 year after transplantation and were evaluated for development of coronary vasculopathy (change in coronary maximal intimal thickness, CMIT). We evaluated serial endomyocardial biopsy specimens for cellular rejection, vascular rejection, ischemia, and fibrosis. In a mathematical model, we computed a biopsy score in each patient based on the duration and severity of histopathology.
Results:
We found a significant correlation between biopsy score (RY) and progression of coronary vasculopathy (r = 0.54, p = 0.001). Using a sensitivity analysis method, an RY value of > or =560 predicted development of coronary vasculopathy with a sensitivity of 86%, specificity of 62%, and diagnostic accuracy of 80%. Compared with patients with low-risk biopsy scores (RY < 560, n = 37), patients with high-risk biopsy scores (RY > or = 560, n = 103) had increased progression of coronary vasculopathy (CMIT, 0.59 +/- 0.29 vs 0.19 +/- 0.10 mm, p < 0.001) and worse 7-year event-free survival (60% vs 91%, p = 0.01).
Conclusion:
The biopsy score is an effective method for predicting the development of coronary vasculopathy and for predicting outcome in cardiac transplant recipients.